Vertex Pharmaceuticals Inc (VRTX) — Capital Reinvestment Ratio
Vertex Pharmaceuticals Inc (VRTX) has a Capital Reinvestment Ratio of 0.10x as of June 2026, meaning it reinvests 0% of its operating cash flow ($1.13 Billion) in capital expenditures ($112.20 Million). Check how tangible is Vertex Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Vertex Pharmaceuticals Inc Capital Reinvestment Ratio (1993–2025)
This chart tracks Vertex Pharmaceuticals Inc's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see how efficiently does Vertex Pharmaceuticals Inc generate cash.
Annual Capital Reinvestment Ratio for Vertex Pharmaceuticals Inc (1993–2025)
Year-by-year Capital Reinvestment Ratio for Vertex Pharmaceuticals Inc from 1993 to 2025. See free cash flow generation of Vertex Pharmaceuticals Inc to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | $3.63 Billion | $437.60 Million | ▲ +65.0% |
| 2023 | 0.07x | $3.54 Billion | $258.40 Million | ▲ +47.4% |
| 2022 | 0.05x | $4.13 Billion | $204.70 Million | ▼ -44.2% |
| 2021 | 0.09x | $2.64 Billion | $235.00 Million | ▲ +11.3% |
| 2020 | 0.08x | $3.25 Billion | $259.80 Million | ▲ +66.1% |
| 2019 | 0.05x | $1.57 Billion | $75.45 Million | ▼ -36.1% |
| 2018 | 0.08x | $1.27 Billion | $95.52 Million | ▼ -75.5% |
| 2017 | 0.31x | $844.94 Million | $259.42 Million | ▲ +28.2% |
| 2016 | 0.24x | $236.10 Million | $56.56 Million | ▼ -9.8% |
| 2012 | 0.27x | $267.84 Million | $71.14 Million | ▼ -59.6% |
| 2011 | 0.66x | $143.74 Million | $94.59 Million | ▲ +214.4% |
| 1993 | 0.21x | $8.60 Million | $1.80 Million | — |